Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Market price (% of par)
-
164.35%
-
Total 13F principal
-
$352,271,743
-
Principal change
-
-$546,666,787
-
Total reported market value
-
$579,144,349
-
Number of holders
-
43
-
Value change
-
-$724,046,330
-
Number of buys
-
17
-
Number of sells
-
50
Institutional Holders of ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 as of Q3 2025
As of 30 Sep 2025,
ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 was held by
43 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$352,271,743
in principal (par value) of the bond.
The largest 10 bondholders included
Voya Investment Management LLC, BNP PARIBAS FINANCIAL MARKETS, STATE STREET CORP, MANUFACTURERS LIFE INSURANCE COMPANY, THE, FMR LLC, MACKAY SHIELDS LLC, LMR Partners LLP, Parallax Volatility Advisers, L.P., BlackRock, Inc., and LORD, ABBETT & CO. LLC.
This page lists
43
institutional bondholders reporting positions
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.